State of the Union - Innovation Agenda, COVID PHE & Supply Chain, Drug Reforms & Insulin | Capitol Street

Published On: 02/28/2022 ▪

State of the Union – Innovation Agenda, COVID PHE & Supply Chain, Drug Reforms & Insulin

Innovation Agenda, COVID PHE & Supply Chain, Drug Reforms & Insulin

Access memo here

View More Posts

USPSTF Update: Diagnostic Testing Under Fire? Two US Preventive Task Force Leaders Ousted
Published On: 05/20/2026
TrumpRx Incorporates CostPlus, Amazon & GoodRx
Published On: 05/19/2026
Final ‘27 Marketplace Rule Consistent with OBBBA
Published On: 05/18/2026
Medicare Advantage Risk Model Unlikely Anytime Soon
Published On: 05/15/2026
House Pushes to Ban China Trial Data for INDs
Published On: 05/12/2026
Acting FDA Commissioner Possibilities
Published On: 05/08/2026
CRUSH: National MolDX Program Unlikely Near-Term
Published On: 05/06/2026
Health Policy Peek: Week of May 4-8
Published On: 05/01/2026
FDA Unveils Real Time Clinical Trial Pilots with AI
Published On: 04/28/2026
Hospitals: Ahead of CEO Hearing Paragon Lays Out Reform Ideas
Published On: 04/27/2026

What insights can we share with you?

Contact Info

900 19th Street Northwest
Washington, DC 20006
United States
team@capitol-street.com

PastedGraphic-26